O
Oppenheimer Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
501
AngioDynamics
ANGO
$442M
|
SL
Steven Lichtman
| $10.87 | $12 |
10%
upside
| Outperform |
5 Apr ‘24
1 year ago |
|
502
Microvast
MVST
$903M
|
CR
Colin Rusch
| $2.79 | $4 |
43%
upside
| Outperform |
2 Apr ‘24
1 year ago |
|
503
DURECT Corp
DRRX
$60.2M
|
FB
Francois Brisebois
| $1.94 | $5 |
158%
upside
| Outperform |
1 Apr ‘24
1 year ago |
|
|
WPRT
504
Westport Fuel Systems
WPRT
$40.9M
|
CR
Colin Rusch
| $2.36 | $19 |
705%
upside
| Outperform |
27 Mar ‘24
1 year ago |
|
505
Forge Global Holdings
FRGE
$241M
|
OL
Owen Lau
| $17.70 | $52.50 |
197%
upside
| Outperform |
27 Mar ‘24
1 year ago |
|
506
Cognition Therapeutics
CGTX
$214M
|
JO
Jay Olson
| $2.43 | $9 |
270%
upside
| Outperform |
27 Mar ‘24
1 year ago |
|
507
Agilent Technologies
A
$35.8B
|
IZ
Ian Zaffino
| $126.20 | $90 |
29%
downside
| Outperform |
26 Mar ‘24
1 year ago |
|
|
BCIC
508
BCP Investment Corporation Common Stock
BCIC
$162M
|
MP
Mitchel Penn
| $12.28 | $20 |
63%
upside
| Perform |
15 Mar ‘24
1 year ago |
|
509
Trimble
TRMB
$19.2B
|
CR
Colin Rusch
| $80.59 | $72 |
11%
downside
| Outperform |
14 Mar ‘24
1 year ago |
|
510
Inovio Pharmaceuticals
INO
$146M
|
HS
Hartaj Singh
| $2.75 | $40 |
1,355%
upside
| Outperform |
8 Mar ‘24
1 year ago |
|
511
Stellus Capital Investment Corp
SCM
$423M
|
MP
Mitchel Penn
| $14.89 | $14 |
6%
downside
| Perform |
6 Mar ‘24
1 year ago |
|
512
W.W. Grainger
GWW
$47.3B
|
CG
Christopher Glynn
| $988.76 | $1,125 |
14%
upside
| Outperform |
5 Mar ‘24
1 year ago |
|
513
Compass Diversified
CODI
$535M
|
MP
Mitchel Penn
| $7.11 | $23 |
223%
upside
| Perform |
5 Mar ‘24
1 year ago |
|
514
Horizon Technology Finance
HRZN
$291M
|
MP
Mitchel Penn
| $6.84 | $10 |
46%
upside
| Perform |
1 Mar ‘24
1 year ago |
|
515
Taboola.com
TBLA
$1.02B
|
JH
Jason Helfstein
| $3.44 | $6 |
74%
upside
| Outperform |
29 Feb ‘24
1 year ago |
|
516
Okta
OKTA
$16.4B
|
IK
Ittai Kidron
| $92.75 | $125 |
35%
upside
| Outperform |
29 Feb ‘24
1 year ago |
|
517
Merit Medical Systems
MMSI
$5.4B
|
SL
Steven Lichtman
| $91.11 | $87 |
5%
downside
| Outperform |
29 Feb ‘24
1 year ago |
|
518
Immunocore
IMCR
$1.83B
|
JK
Justin Kim
| $36.39 | $87 |
139%
upside
| Outperform |
29 Feb ‘24
1 year ago |
|
519
Clarivate
CLVT
$2.98B
|
OL
Owen Lau
| $4.43 | $10 |
126%
upside
| Outperform |
28 Feb ‘24
1 year ago |
|
520
Nice
NICE
$8.84B
|
TH
Timothy Horan
| $143.14 | $300 |
110%
upside
| Outperform |
23 Feb ‘24
1 year ago |
|
521
Crescent Capital BDC
CCAP
$583M
|
MP
Mitchel Penn
| $15.73 | $19 |
21%
upside
| Outperform |
23 Feb ‘24
1 year ago |
|
522
DigitalOcean
DOCN
$3.09B
|
TH
Timothy Horan
| $33.98 | $46 |
35%
upside
| Outperform |
22 Feb ‘24
1 year ago |
|
523
Shake Shack
SHAK
$3.9B
|
MT
Michael Tamas
| $96.94 | $108 |
11%
upside
| Outperform |
16 Feb ‘24
1 year ago |
|
524
Five Below
FIVE
$7.81B
|
BN
Brian Nagel
| $141.66 | $200 |
41%
upside
| Perform |
30 Jan ‘24
1 year ago |
|
525
American Express
AXP
$225B
|
DG
Dominick Gabriele
| $323.31 | $219 |
32%
downside
| Outperform |
29 Jan ‘24
1 year ago |
|